Results 1 to 10 of about 41,841 (256)

Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration

open access: yesSignal Transduction and Targeted Therapy, 2022
Silicosis is the most prevalent and fatal occupational disease with no effective therapeutics, and currently used drugs cannot reverse the disease progress.
Ming-yao Wang, Junling Pang, Hao Yang
exaly   +3 more sources

Silica, Silicosis, and Autoimmunity [PDF]

open access: yesFrontiers in Immunology, 2016
Inhalation of dust containing crystalline silica is associated with a number of acute and chronic diseases including systemic autoimmune diseases. Evidence for the link with autoimmune disease comes from epidemiological studies linking occupational exposure to crystalline silica dust with the systemic autoimmune diseases systemic lupus erythematosus ...
Kenneth Michael Pollard
exaly   +6 more sources

The role of inflammation in silicosis

open access: yesFrontiers in Pharmacology
Silicosis is a chronic illness marked by diffuse fibrosis in lung tissue resulting from continuous exposure to SiO2-rich dust in the workplace. The onset and progression of silicosis is a complicated and poorly understood pathological process involving ...
Tong-Tong Liu   +4 more
doaj   +4 more sources

Blocking Caspase-1/Gsdmd and Caspase-3/-8/Gsdme pyroptotic pathways rescues silicosis in mice

open access: yesPLoS Genetics, 2022
Millions of patients suffer from silicosis, but it remains an uncurable disease due to its unclear pathogenic mechanisms. Though the Nlrp3 inflammasome is involved in silicosis pathogenesis, inhibition of its classic downstream factors, Caspase-1 and ...
Lulu Kang   +12 more
doaj   +3 more sources

Current global perspectives on silicosis—Convergence of old and newly emergent hazards

open access: yesRespirology, 2022
Silicosis not a disease of the past. It is an irreversible, fibrotic lung disease specifically caused by exposure to respirable crystalline silica (RCS) dust.
Mohamed F Jeebhay   +2 more
exaly   +2 more sources

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis

open access: yesInternational Journal of Molecular Sciences, 2021
Inhalation of silica particles is an environmental and occupational cause of silicosis, a type of pneumoconiosis. Development of the lung silicosis is a unique process in which the vicious cycle of ingestion of inhaled silica particles by alveolar ...
Daniela Mokra
exaly   +2 more sources

Silicosis as a predictor of tuberculosis mortality and treatment failure and need for incorporation in differentiated TB care models in India

open access: yesArchives of Public Health, 2023
Background Differentiated tuberculosis (TB) care is an approach to improve treatment outcomes by tailoring TB management to the particular needs of patient groups based on their risk profile and comorbidities. In silicosis-prone areas, the coexistence of
Mihir P. Rupani
doaj   +2 more sources

Early Identification, Accurate Diagnosis, and Treatment of Silicosis

open access: yesCanadian Respiratory Journal, 2022
Silicosis is a global problem, and it has brought about great burdens to society and patients’ families. The etiology of silicosis is clear, preventable, and controllable, but the onset is hidden and the duration is long.
Tian Li   +3 more
doaj   +2 more sources

Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment

open access: yesFrontiers in Genetics, 2021
Silicosis is a fatal occupational lung disease which currently has no effective clinical cure. Recent studies examining the underlying mechanism of silicosis have primarily examined experimental models, which may not perfectly reflect the nature of human
Junling Pang   +13 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy